DHI vs REPL · P/E 9.6, rev $34.25B vs $825.7M cap
DR Horton Inc (DHI) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
DR Horton Inc (DHI) is a residential construction company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
REPL does not have a complete income-statement cache yet.
DHI currently screens at market cap $39.10B and trailing P/E 9.6. REPL currently screens at market cap $825.7M.
Not investment advice. Open the DHI and REPL stock pages for the full models.
Not investment advice.